86
Limb GA, Matter K, Murphy G, Cambrey AD, Bishop PN, Morris GE. Matrix
metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin
a/c degradation during apoptosis. Am J Pathol 2005; 166:1555–63.
Lino Y, Imamura Y, Kojima C, Takegoshi S, Suzuki JI. Risk factors for recurrent and
residual cholesteatoma in children determined by second stage operation. Int J Ped
Otorhinolaryngol. 1998, 46(1-2):57-65.
Llano E, Pendas AM, Freije JP, Nakano A, Knäuper V, Murphy G, López-Otín C.
Identification and characterization of human mt5-mmp, a new membrane-bound activator of
progelatinase a overexpressed in brain tumors. Cancer Res. 1999; 59:2570–6.
Luo D, Mari B, Stoll I, Anglard P. Alternative splicing and promoter usage generates an
intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase. J
Biol Chem 2002; 277:25527–36.
Mafee M. MRI and CT in the evaluation of acquired and congenital cholesteatomas of
temporal bone. J Otolaryngol. 1993; 22:239-48. In Tessa JRG, Vivente AO, Abreu CEC,
Bendassat SF, Antunes ML, Barros FA. Colesteatoma causando paralisia facial. Rev Bras
ORL 2003, 69(5):657–62.
Marcato P, Giuritti P, Pozzo T, Vitiello R, Valente G, Giordano C, Sartoris A. Chronic
cholesteatomatous otitis media: the histopathological and clinical aspects. Acta
Otorhinolaryngol Ital. 1991; 11(5):465-70.
Marenda BA, Audfemorte TB. Localization of cytokines in cholesteatoma tissue. Otolaryngol
Head Neck Surg.1995; 112 (3):359-68.
Matrisian LM Quick guide. Matrix metalloproteinases. Curr Biol. 2000; 10(19):R692.
Matrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet
1990; 6:121-5.
Matter R, Schweiger C, Hemb L, Smith M, Schmidt L, Dornelles C, Costa SS. Estudo da
orelha contralateral na otite média crônica, em pacientes pediátricos. Revista on-line do
HCPA, www.hcpa.ufrgs.br, 2003.
Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC,
Pugh CW, Maher ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-
inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271–275
Mayot D, Bénè MC, Faure GC, Wayoff M, Perrin C. Immunohistologic analysis of the
cholesteatoma matrix in children. Int J Ped Otorhinolaryngol. 1991, 22(2):115-24.
McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to
tumor progression. Mol Med Today 2000; 6:149-56.
McCawley LJ, Matrisian LM. Matrix metalloproteinases: they’re not just for matrix anymore!
Curr Opin Cell Biol. 2001;13:534–40.
Medina C, Radomski MW. Role of matrix metalloproteinases in intestinal inflammation. J
Pharmacol Exp Ther. 2006 Sep;318(3):933-8.
Meurer L. Densidade microvascular e expressão imunoistoquímica de p21: associação com
sobrevida em pacientes submetidos à cirurgia por carcionama epidermóide de esôfago [tese].
Porto Alegre, UFRGS, 2003.
Meyerhoff WL, Wright CG, Gerken GM. Effects of middle ear ventilation on cholesteatoma
development in experimental animals. Acta Otolaryngol. 1990; 110(3-4):279-85.